PubMed · 1978 · 743 citations · 0 references
PharmacyPharmacokineticsPharmacologyCancer PharmacologyDrug ClearancePharmacokinetics Of Anticancer AgentsAbsorption Of Anticancer DrugsGynecologic Cancer PharmacotherapyOvarian CancerOvarian Cancer PharmacotherapyPeritoneal DialysisPharmacokinetics Of Anticancer DrugsAnticancer ChemotherapyConcentrationDistribution Of Hydrophilic DrugsDrug Clearance During Peritoneal DialysisIntraperitoneal BioavailabilityOvarian Cancer TreatmentPeritoneal Dialysis PharmacokineticsPharmacokinetic Calculations
Evidence from the peritoneal dialysis literature suggests that the peritoneal permeability of a number of hydrophilic anticancer drugs may be considerably less than plasma clearance. Pharmacokinetic calculations indicate that such drugs administered ip in large volumes are expected to maintain a significantly greater concentration in the peritoneal space than in the plasma. This concentration difference offers a potentially exploitable biochemical advantage in the treatment of patients with presumed microscopic residual ovarian cancer confined to the peritoneal cavity.